The need to develop responsible marketing practice in the pharmaceutical sector

Problems and Perspectives in Management

Volumn 2, Issue 4, 2004, Pages 92-103

  Buckley, Joan ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Advertising; Pharmaceutical marketing

Indexed keywords

EID: 78149388533     PISSN: 17277051     EISSN: 18105467     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. ABPI (2003) "Code of Practice for the Pharmaceutical Industry 2003" Association of the British Pharmaceutical Industry: London.
2. Aitken, M., Holt, F. (2000) "A prescription for direct drug marketing" The McKinsey Quarterly 22 Mar; 82.
3. Banks, JW, Mainour, AG (1992) "Attitudes of medical school faculty towards gifts from the pharmaceutical industry" Acad Med 67: 610-612.
4. Barnes, M.L. (2003) "Marketing to a segment of one" Pharmaceutical Executive March
5. www.bbc.co.uk (2000)- "G.P.s seize on Prozac to treat PMS" 29 Sep 2000.
6. Blondeel, L. (1997) "Advertisement for nifedipine does not mention admitted shortcomings of study" British Medical Journal 315: 1621.
7. Bloom, B.S. (1999) Annals of Internal Medicine Dec 7.
8. Boseley, S. (1999) "Drug firm asks public to insist NHS buys its product" The Guardian 29 Sept.
9. Brooks, A. (1998) "Viagra is licensed in Europe but rationed in Britain" British Medical Journal 317:765.
10. Burton, B. (2003) "Ban Direct to Consumer Advertising , Report Recommends" British Medical Journal 326:467.
11. Burton, B., Rowell, A. (2003) "Unhealthy spin" British Medical Journal 326: 1205-1207.
12. Calfee, J. (2002) "Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs" Journal of Public Policy and Marketing 21 (2) 174-193.
13. Canadian Medical Association Journal (2003) Sep 30, 169 (7).
14. Chren, MM, Landefeld CS, Murray TH (1989) "Doctors, drug companies and gifts" Journal of the Australian Medical Association 262: 3448-3451.
15. Chren, MM, Landefeld S (1994) "Physicians' behaviour and their interactions with drug companies" Journal of the Australian Medical Association 271: 684-689.
16. Corstjens, M. (1991) Marketing Strategy in the Pharmaceutical Industry Chapman & Hall: London.
17. Cutting Edge (2003) "Early-Stage Pharmaceutical Marketing: Uniting R&D and Commercialisation" (Mindbranch: Williamstown, MA).
18. Davidoff, F., DeAngelis C.D., Drazen, J.M., Hoey, J., Hojgaard, L., Horton, R. et al (2001) "Sponsorship, Authorship and Accountability" Lancet 358.
19. De Mortanges, C.P., Rietbrock, JW (1997) "Marketing pharmaceuticals in Japan: Background and the experience of US firms" European Journal of Marketing 31 (7/8) 561-582.
20. Eagle, L. and P. Kitchen (2002) "Direct consumer promotion of prescription drugs: A review of the literature and the New Zealand experience" International Journal of Medical Marketing 2,4 293-310.
21. EFPIA (2002) The Pharmaceutical Industry in Figures 2002 edition European Federation of Pharmaceutical Industries and Associations: Brussels.
22. English-Maher, M. (2003) "The Role of the Clinician in Service Delivery" unpublished M.Sc research work .
23. Essif, M. (2001) "Prescription drugs are crossing borders to buyers" CNN.com Mar 12.
24. Ess, S.M., Schneeweiss, S., Szucs, T.D. (2003) "European Healthcare Policies for Controlling Drug Expenditure" Pharmacoeconomics 21(2) 89-103.
25. Farrell, L. (2000) "O Liberty! What crimes are committed in thy name!" British Medical Journal 321:578.
26. Flynn, L.T. (1999) "Does direct to consumer advertising of prescription drugs benefit the public's health? - Yes" in American Council on Science and Health 11,4.
27. Gopal, K. (2002) "GSK face bribe charges, changing of the guard" Pharmaceutical Executive April 2002.
28. Gottlieb, S. (2002) "Congress criticizes drugs industry for misleading advertising" British Medical Journal 325:137.
29. Hayes, T.M., Allery, L.A., Harding, K.G., Owen, P.A. (1990) "Continuing education for general practice and the role of the pharmaceutical industry" British Journal of General Practice 40 (341) 510.
30. Healthy Skepticism New Zealand (2000) "Does direct to consumer promotion of Viagra risk lives?" Healthy Skepticism New Zealand 3 (1).
31. Herxheimer, A. (2003) "Relationships between the pharmaceutical industry and patient organisations" British Medical Journal 326: 1208-1210.
32. Horrobin, D.F. (2000) "Innovation in the pharmaceutical industry" Journal of the Royal Society of Medicine Jul 93, 341-345.
33. ICC (2002) "International Code of Practice of Sales Promotion" International Chamber of Commerce www.iccwbo.org.
34. IPHA (1999) "Code of Marketing Practice for the Pharmaceutical Industry" Irish Pharmaceutical Healthcare Association: Dublin.
35. Jeffries, M. (2000) "The Mark of Zorro" Pharmaceutical Marketing May 45.
36. Kohn, C. and C.W. Henderson (2004) "AMA condemns illegal pharmacies, stresses patient- physician relationship" Managed Care Weekly Digest 4/12/2004, p. 77, 1p.
37. Komesaroff, P.A., Kerridge, I.H. (2002) "Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry" The Medical Journal of Australia 2 Feb 176 3:118-121.
38. Lerer, L. (2002) "Pharmaceutical marketing segmentation in the age of the Internet" International Journal of Medicine Marketing 2,2 159-166.
39. Lexchin, J., Mintzes, B. (2002) "Direct-to-consumer advertising of prescription drugs: the evidence says no" Journal of Public Policy and Marketing 21(2) 194-202.
40. Light, D.W. and Lexchin, J. (2003) "Will Lower Drug Prices Jeopardise Drug Research? A Policy Fact Sheet" The American Journal of Bioethics 4:1.
41. Maguire, P. (1999) "How direct to consumer advertising is putting the squeeze on physicians" American College of Physicians - American Society of Internal Medicine Observer March.
42. Light, D.W. and Lexchin, J. (2003) "Will Lower Drug Prices Jeopardise Drug Research? A Policy Fact Sheet" The American Journal of Bioethics 4:1.
43. McInney WP, Schiedermeyer DL, Lurie N et al (1990) Attitudes of internal medicine faculty and residents towards professional interaction with pharmaceutical sales representatives" Journal of the Australian Medical Association 264: 1693-1697.
44. Medawar, C. (1997) "The Antidepressant Web - marketing depression and making medicines work" International Journal of Risk and Safety in Medicine 10,2,75-126.
45. Medawar, C. (2002) "Promotion of prescription drugs: trade tactics?" Consumer Policy Review 12, 1.
46. Medical Marketing and Media (2003) "Court Documents Show Merck Medco received $3 billion in pharma rebates" editorial Medical Marketing and Media April 4, 3.
47. Mintzes, B. (2002) "Direct to consumer advertising is medicalising normal human experience" British Medical Journal 324: 908-911.
48. Mintzes, B., Barer, M.L., Kravitz, R.L., Kazanjian, A., Bassett, K., Lexchin, J., Evans, R.G., Pan, R., Marion, S.A. (2002) "Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey" British Medical Journal 324: 278-279.
49. Moynihan, R. (2003) "Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement" British Medical Journal 326: 1189-1192.
50. Moynihan, R. (2003) "Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement" British Medical Journal 326: 1193-1196 .
51. Oldham, J. (2003) "Mood drug attacker avoids jail" The Scotsman Jun 19.
52. PhRMA (2002) "PhRMA code on interactions with healthcare professionals" in www.phrma.org/publications/policy/2002-04-19.391.pdf.
53. Peay, M.Y., Peay, E.R. (1988) "The role of commercial sources in the adoption of a new drug" Soc Sci Med 26: 1183-1189.
54. Prawirosujanto, S. (2001) "Doctors Prescriptions" Jakarta Post 29th June 2001.
55. Quality and Safety in Healthcare April 2003.
56. Rees, J. (2003) "Development of community regulation in the chemical industry" Law and Policy 19,4 pp. 447-528.
57. Revill, J. (2003) "Female sex illness: is it in the head or in the genes?" The Observer Jan 5.
58. Riccardi, F. (2002) "Healthcare Providers and Pharmaceutical Companies: Is there a prescription for Ethical Relationships?" Journal of Health Care Compliance Jul-Aug 4-8.
59. Robinson, J. (2001) "Prescription Games" Simon and Schulster: London.
60. Shapiro, J.P., Shultz, S. (2001) "Prescriptions: How your doctor makes the choice" U.S. News and World Report 130:7 58-62.
61. Smith, R. (2003) "Medical journals and pharmaceutical companies: uneasy bedfellows" British Medical Journal 326: 1202-1205.
62. Stern, P., Ehrenberg, A. (2003) "Expectations vs. Reality" Marketing Research 15 (1).
63. Strout, E. (2001) "Doctoring Sales" Sales and Marketing Management 153:5 53-61.
64. Thomas, L. (1980) "The Medusa and the Snail" New York: Bantam Books.
65. Thomson, A.N., Craig, B.J., Barnham, P.M. (1994) "Attitudes of general practitioners in New Zealand to pharmaceutical representatives" British Journal of General Practice 44, 220-223.
66. Turone, F. (2003) "Italian police investigate GSK Italy for bribery" British Medical Journal 326:413.
67. Wazana, A. (2000) "Physicians and the pharmaceutical industry. Is a gift ever just a gift?" Journal of the Australian Medical Association 283: 373-380.